Ngā hua rapu - Yiming ZENG
-
1
Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI
I whakaputaina 2025-06-01Whiwhi kuputuhi katoaEGFR-mutant non-small cell lung cancer (NSCLC) is a common type of lung cancer, with EGFR tyrosine kinase inhibitors (EGFR-TKIs) being the standard first-line treatment. However, most patients with NSCLC eventually develop resistance to EGFR-TKIs. Studies on the mechanism underlying EGFR-TKI resista...
Tuhinga -
2
Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035
I whakaputaina 2025-07-01Whiwhi kuputuhi katoaBackgroundHigh body mass index (BMI) is a major modifiable risk factor for chronic kidney disease (CKD), significantly contributing to its global burden. This study aimed to systematically evaluate the global burden of CKD attributable to high BMI from 1990 to 2021, identify demographic and regional...
Tuhinga